RPL30P15

Across TCGA pan-cancer cohorts, RPL30P15 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPL30P15 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RPL30P15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL30P15 expression acts as an unfavorable survival marker, although some lineages such as BLCA and OV show a favorable association.

SKCM, MESO, and UCS are the cancer types where RPL30P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.430	0.635	<.001	60	view →
MESO	OS	Tertile	II,III,IV	0.224	0.582	.002	45	view →
UCS	OS	Tertile	III,IV	0.277	0.635	.012	36	view →
UCEC	DFS	Tertile	IV	0.317	0.734	.010	36	view →
PAAD	OS	Tertile	All	0.368	0.646	.005	18	view →
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	18	view →
BLCA	OS	Tertile	II,III,IV	0.801	0.401	.017	12	view →
STAD	DFS	Tertile	II,III,IV	0.373	0.591	.026	12	view →
KIRC	DFS	Tertile	All	0.698	0.812	.029	12	view →
KIRP	OS	Tertile	All	0.610	0.906	.030	9	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	9	view →
THCA	OS	Tertile	IV	0.626	1.000	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPL30P15–SKCM (DFS)

Open the SKCM breakdown →